High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer

High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer

Objective: While immunotherapy holds great potential for triple-negative breast cancer (TNBC), the lack of non-invasive biomarkers to identify beneficiaries limits the application. Methods: Paired baseline, on-treatment, and post-treatment plasma samples were collected from 195 TNBC patients receivi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang, Jinxiu Shi
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2025-07-01
Series:	Cancer Biology & Medicine
Subjects:	triple-negative breast cancer immunotherapy non-invasive biomarkers efficacy prediction plasma proteomic profiling
Online Access:	https://www.cancerbiomed.org/content/22/7/854
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Extracellular Vesicle Proteome Analysis Improves Diagnosis of Recurrence in Triple‐Negative Breast Cancer
by: Ju‐Yong Hyon, et al.
Published: (2025-06-01)

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
by: Lijuan Weng, et al.
Published: (2024-03-01)

YX-112, a novel celastrol-derived PROTAC, inhibits the development of triple-negative breast cancer by targeting the degradation of multiple proteins
by: Yongxue Gu, et al.
Published: (2025-04-01)

Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study
by: Yun-Yi Wang, et al.
Published: (2025-08-01)

Dynamic cardiac changes in low cardiovascular risk patients with triple negative breast cancer treated with chemo-immunotherapy
by: Jean Philippe Nesseler, et al.
Published: (2025-07-01)

Triple-negative breast cancer: Pattern of recurrence and survival outcomes
by: Shyny Reddy Chintalapani, et al.
Published: (2019-01-01)

Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of Triple-negative breast cancer
by: Xiaoman Xu, et al.
Published: (2025-08-01)

Homologous targeted neutrophils-liposome system for pyroptosis-enhanced antitumor immunotherapy of triple-negative breast cancer
by: Ge Gao, et al.
Published: (2025-06-01)

c-MYC Levels and Metabolic Parameters in Triple-Positive and Triple-Negative Breast Cancer
by: Doaa N. Abood, et al.
Published: (2025-06-01)

Immunotherapy for triple-negative breast cancer: current trends and future prospects
by: Amina Essalihi, et al.
Published: (2025-06-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01)

The integrated single-cell analysis interpret the lactate metabolism-driven immune suppression in triple-negative breast cancer
by: Xinhai Gao, et al.
Published: (2025-05-01)

Construction of a stromal cell-related prognostic signature based on a 101-combination machine learning framework for predicting prognosis and immunotherapy response in triple-negative breast cancer
by: Fanrong Li, et al.
Published: (2025-05-01)

Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
by: Chang Cheng, et al.
Published: (2025-01-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01)

Caveolin-1 in Tumour Cells is Predominately Expressed in the Basal Subtype of Triple-Negative Breast Carcinoma
by: Savelina Popovska, et al.
Published: (2014-11-01)

Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis
by: Neya Ramanan, et al.
Published: (2025-05-01)

Profiling triple-negative breast cancer-specific super-enhancers identifies high-risk mesenchymal development subtype and BETi-Targetable vulnerabilities
by: Qing-shan Chen, et al.
Published: (2025-05-01)

RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
by: Jialin Yuan, et al.
Published: (2025-01-01)

Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis
by: Shihao Sun, et al.
Published: (2025-08-01)

The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
by: Chikako Funasaka, et al.
Published: (2025-01-01)

Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
by: Ruiliang Chen, et al.
Published: (2024-12-01)

Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
by: Weiwei Zeng, et al.
Published: (2023-11-01)

Ferroptosis-related gene signature-based subtype identification of triple-negative breast cancer to prioritize treatment strategies
by: Yongzhen Chen, et al.
Published: (2025-05-01)

Central nervous system relapse in triple-negative breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy: A retrospective cohort analysis
by: Gabriel Berlingieri Polho, et al.
Published: (2025-10-01)

Association Between Anti‐TIF1‐γ Antibody and Triple‐Negative Breast Carcinoma in Dermatomyositis Patients: A Case Report
by: Fan Zhang, et al.
Published: (2025-02-01)

Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review
by: Herleeyana Meriyani, et al.
Published: (2025-02-01)

LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target
by: Qiqi Xue, et al.
Published: (2025-03-01)

Analysis of survival differences in advanced triple-negative breast cancer: a real-world study
by: Jun-Sheng Zheng, et al.
Published: (2025-08-01)

Zinc-copper bimetallic nanoplatforms trigger photothermal-amplified cuproptosis and cGAS-STING activation for enhancing triple-negative breast cancer immunotherapy
by: Bangyi Zhou, et al.
Published: (2025-02-01)

Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine
by: Saif Khan, et al.
Published: (2024-12-01)

TIPE regulates glucometabolic reprogramming by modulating LDHA expression in triple-negative breast cancer
by: HU Wei, REN Xiaomeng, WANG Yang, ZHAO Peiqing, CAO Kai
Published: (2025-04-01)

Corrigendum: Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
by: Weiwei Zeng, et al.
Published: (2025-06-01)

SPP1 mRNA Expression Is Associated with M2 Macrophage Infiltration and Poor Prognosis in Triple-Negative Breast Cancer
by: Yu-Chia Chen, et al.
Published: (2024-11-01)

USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stability
by: Pu Wu, et al.
Published: (2025-12-01)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01)

Synthesis of Zinc Oxide-Doped Carbon Dots for Treatment of Triple-Negative Breast Cancer
by: Wang M, et al.
Published: (2024-12-01)

Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options
by: Xin-xian Cai, et al.
Published: (2025-05-01)